Concerns regarding use of Patient Reported Outcomes in Biomarker Studies of Chemotherapy-Induced Peripheral Neuropathy

por Hertz, Daniel L.
Publicado 2019

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy

por Marcath, Lauren A., Finley, Colin M., Wong, Siu Fun, Hertz, Daniel L.
Publicado 2021

2043: Pharmacokinetic prediction of paclitaxel-induced peripheral neuropathy

por Hertz, Daniel L., Kidwell, Kelley M., Vangipuram, Kiran, Sun, Duxin, Henry, N. Lynn
Publicado 2018

Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancer

por Dempsey, Jacqueline M., Xi, Jingyue, Henry, N. Lynn, Rae, James M., Hertz, Daniel L.
Publicado 2018

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials

por Marcath, Lauren A., Coe, Taylor D., Hoylman, Emily K., Redman, Bruce G., Hertz, Daniel L.
Publicado 2018

Comparison of Nine Tools for Screening Drug-Drug Interactions of Oral Oncolytics

por Marcath, Lauren A., Xi, Jingyue, Hoylman, Emily K., Kidwell, Kelley M., Kraft, Shawna L., Hertz, Daniel L.
Publicado 2018

Chemotherapy-Induced Peripheral Neuropathy Detection via a Smartphone App: Cross-sectional Pilot Study

por Chen, Ciao-Sin, Kim, Judith, Garg, Noemi, Guntupalli, Harsha, Jagsi, Reshma, Griggs, Jennifer J, Sabel, Michael, Dorsch, Michael P, Callaghan, Brian C, Hertz, Daniel L
Publicado 2021

Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer

por Hertz, Daniel L., Smith, Karen Lisa, Zong, Yuhua, Gersch, Christina L., Pesch, Andrea M., Lehman, Jennifer, Blackford, Amanda L., Henry, N. Lynn, Kidwell, Kelley M., Rae, James M., Stearns, Vered
Publicado 2021

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Gr...

por Caudle, Kelly E., Sangkuhl, Katrin, Whirl‐Carrillo, Michelle, Swen, Jesse J., Haidar, Cyrine E., Klein, Teri E., Gammal, Roseann S., Relling, Mary V., Scott, Stuart A., Hertz, Daniel L., Guchelaar, Henk‐Jan, Gaedigk, Andrea
Publicado 2019

Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in post-menopausal patients with breast cancer

por Hertz, Daniel L., Kidwell, Kelley M., Seewald, Nicholas J., Gersch, Christina L., Desta, Zeruesenay, Flockhart, David A, Storniolo, Ana-Maria, Stearns, Vered, Skaar, Todd C, Hayes, Daniel F, Henry, N. Lynn, Rae, James M.
Publicado 2016

Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221

por Chen, Ciao-Sin, Zirpoli, Gary, Thomas Budd, G., Barlow, William E., Pusztai, Lajos, Hortobagyi, Gabriel N., Albain, Kathy S., Godwin, Andrew K., Thompson, Alastair, Lynn Henry, N., Ambrosone, Christine B., Stringer, Kathleen A., Hertz, Daniel L
Publicado 2023

Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot stud...

por Salgado, Teresa M., Liu, Jin, Reed, Holly L., Quinn, Caroline S., Syverson, Jillian G., Le-Rademacher, Jennifer, Lopez, Camden L., Beutler, Andreas S., Loprinzi, Charles L., Vangipuram, Kiran, Smith, Ellen M. Lavoie, Henry, N Lynn, Farris, Karen B., Hertz, Daniel L.
Publicado 2020